![]() Robert Rodriguez, M.D., Professor of Emergency Medicine, University of California San Francisco.Loyce Pace, MPH, Executive Director and President, Global Health Council.Michael Osterholm, Ph.D., Director, Center for Infectious Disease Research and Policy, University of Minnesota.Julie Morita, M.D., Executive Vice President, Robert Wood Johnson Foundation.Celine Gounder, M.D., Assistant Professor, NYU Grossman School of Medicine.Atul Gawande, M.D., Surgeon, Brigham and Women's Hospital, and Professor of Surgery, Harvard Medical School.Ezekiel Emanuel, M.D., Ph.D., former Chief of Bioethics Department, NIH Clinical Center Obama Administration health adviser.Rick Bright, Ph.D., former Director, Biomedical Advanced Research and Development Authority (BARDA).Luciana Borio, M.D., Vice President, In-Q-Tel, former Director for Medical and Biodefense Preparedness, National Security Council.Marcella Nunez-Smith, M.D., Co-Chair, Associate Dean for Health Equity Research, Yale University.David Kessler, M.D., Co-Chair, 17th Commissioner of Food and Drugs, FDA.Vivek Murthy, M.D., Co-Chair, 19th U.S.Members of the COVID-19 Advisory Board include: In anticipation of its extensive and focused work to combat COVID-19, the transition team for President-Elect Joe Biden has assembled a COVID-19 Advisory Board, which includes scientific experts, former government officials and others who will help guide the nascent Administration in its efforts to combat the virus. Biden Administration COVID-19 Advisory Board For more information, refer to this updated vaccine tracker or similar public information sources that are providing daily updates on the status of the vaccine candidates as they approach some form of FDA approval. Food and Drug Administration's (FDA) Emergency Use Authorization (EUA) process, and that it may happen shortly. ![]() Many observers anticipate that at least two vaccine candidates will be authorized under the U.S. Army Materiel Command, to serve as OWS Chief Operating Officer on July 2, 2020, and Moncef Slaoui, Ph.D., formerly of GlaxoSmithKline, as Chief Adviser.Īlthough many vaccine candidates have been considered, there are a handful of companies in various late stages of development that were monetarily and publicly supported by OWS. The White House tapped General Gustave Perna, a four-star general and former commanding general of U.S. The federal process to work with these companies became what is known as Operation Warp Speed (OWS), which is a partnership among federal agencies, including the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), the Biomedical Advanced Research and Development Authority (BARDA), and the U.S. Vaccine CandidatesĪt the beginning of the COVID-19 pandemic, more than 50 companies rushed to position themselves as potential candidates for the development of a safe and effective COVID-19 vaccine. This Holland & Knight alert provides an overview of various activities within and outside of the federal government to address these issues, as well as who will or may be in charge of these efforts in the near-term. Recently, new advances in the vaccine development race, as well as the transition from the Trump Administration to a Biden Administration, have generated new questions about how a vaccine would be authorized, approved, and equitably and safely delivered to hundreds of millions of Americans. government, Congress and external entities have worked to design plans to reduce the impact of COVID-19 and ultimately prepare for the development and distribution of a vaccine to the American public. ![]() Since March 2020, and in some cases before, the U.S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |